PRESS RELEASE published on 10/05/2023 at 13:00, 1 year 8 months ago Theralase(R) Files US Patent for Enhanced Immunotherapy
PRESS RELEASE published on 09/29/2023 at 13:00, 1 year 8 months ago Theralase(R) Demonstrates 8 Year Shelf Life of Lead Drug Ruvidar(TM)
PRESS RELEASE published on 09/27/2023 at 13:00, 1 year 8 months ago Theralase(R) Successfully Completes Non-GLP Toxicity Analysis for Brain Cancer
PRESS RELEASE published on 09/21/2023 at 22:35, 1 year 8 months ago Theralase(R) Grants Stock Options
PRESS RELEASE published on 09/07/2023 at 10:30, 1 year 9 months ago Theralase(R) Closes Private Placement Equity Financing
PRESS RELEASE published on 08/29/2023 at 22:30, 1 year 9 months ago Theralase Release’s 2Q2023 Interim Financial Statements
PRESS RELEASE published on 06/30/2023 at 22:35, 1 year 11 months ago Theralase(R) Closes Non-Brokered Private Placement Equity Financing
PRESS RELEASE published on 06/06/2023 at 13:00, 2 years ago Theralase(R) Announces Appointment of New Independent Director
PRESS RELEASE published on 05/31/2023 at 03:30, 2 years ago Theralase(R) Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statements
PRESS RELEASE published on 05/31/2023 at 01:35, 2 years ago Theralase(R) Releases 1Q2023 Interim Financial Statements
Published on 06/16/2025 at 15:00, 1 hour 14 minutes ago Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August
Published on 06/16/2025 at 15:00, 1 hour 14 minutes ago Aeonian Resources Reports Highly Anomalous Copper Assay Results from Surface Sampling Program at Koocanusa Project, Southeast British Columbia
Published on 06/16/2025 at 14:50, 1 hour 24 minutes ago 1933 Industries Reports Profit in Third Quarter 2025 Financial Results
Published on 06/16/2025 at 14:30, 1 hour 44 minutes ago Star Copper Announces Closing of C$1.25M Second Tranche of Flow Through Private Placement
Published on 06/16/2025 at 14:30, 1 hour 44 minutes ago DTW 2025: Amdocs Unveils MVNO&GO: A SaaS Platform to Accelerate Digital Connectivity for MVNOs
Published on 06/16/2025 at 16:00, 14 minutes ago Strategic Collaboration Between Xlife Sciences AG, Huraypositive Corp., and OncoMASTER Inc. to Boost Digital Health and Precision Oncology in Asia
Published on 06/16/2025 at 15:17, 56 minutes ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Published on 06/16/2025 at 15:16, 57 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 06/16/2025 at 15:16, 58 minutes ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc
Published on 06/16/2025 at 14:22, 1 hour 52 minutes ago Déclaration des transactions sur actions propres réalisées du 09/06/2025 au 13/06/2025
Published on 06/16/2025 at 14:22, 1 hour 52 minutes ago Statement of transactions in own shares from June 9, 2025 to June 13, 2025
Published on 06/16/2025 at 14:01, 2 hours 12 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 mai 2025
Published on 06/16/2025 at 14:01, 2 hours 12 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as at May 31, 2025
Published on 06/16/2025 at 07:30, 8 hours 44 minutes ago FSDV : obtention du visa de l’AMF sur le prospectus